Nanotechnology for Nucleic Acid Delivery 2012
DOI: 10.1007/978-1-62703-140-0_16
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Lipidic Magnetic Nanoparticles for Nucleic Acid Delivery

Abstract: Lipidic magnetic nanoparticles are a rapid and reliable magnet-guided nucleic acid delivery system, which we have named as "LipoMag" (Namiki et al., Nat. Nanotechnol 4:598-606, 2009). LipoMag is composed of a cationic lipid shell, an oleic acid binder, and an iron oxide nanocrystal core. Through the electrostatic force, positively charged LipoMag and negatively charged nucleic acid form complexes, termed "mag-lipoplex." Under a magnetic field, LipoMag bearing nucleic acid can be controllably accumulated in tar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…For use in therapy, efficient delivery methods need to be developed. There are current efforts to develop adeno-associated virus vectors (Ketzer et al 2012), cationic peptides (Ewert et al 2008), nanoparticles (Chen et al 2012;Namiki 2013), and modified Salmonella strains (Yuhua et al 2001;Bai et al 2011) as delivery vehicles, yet improvements to minimize toxicity and immune responses and increase delivery to target tissues are still needed. Additionally, for the use as a tool in therapy or research, improvements are required to increase splicing efficiency in cells, and reduce off-target effects.…”
Section: Introductionmentioning
confidence: 43%
“…For use in therapy, efficient delivery methods need to be developed. There are current efforts to develop adeno-associated virus vectors (Ketzer et al 2012), cationic peptides (Ewert et al 2008), nanoparticles (Chen et al 2012;Namiki 2013), and modified Salmonella strains (Yuhua et al 2001;Bai et al 2011) as delivery vehicles, yet improvements to minimize toxicity and immune responses and increase delivery to target tissues are still needed. Additionally, for the use as a tool in therapy or research, improvements are required to increase splicing efficiency in cells, and reduce off-target effects.…”
Section: Introductionmentioning
confidence: 43%